Skip to main content
. 1997 Aug 1;17(15):5820–5829. doi: 10.1523/JNEUROSCI.17-15-05820.1997

Fig. 4.

Increased number of BrdU-positive cells in the striatum (A–C), cortex (D–F), and medial septum (G–I) of EGF- and FGF-2-treated animals at the end of infusion. D–F, Note the increase of BrdU-positive cells along the cannula tract in the cerebral cortex (on the left side of the images). Shown are confocal microscopic images with immunofluorescent triple labeling for BrdU (green), NeuN (red), and S100β (blue). Scale bar in A, 200 μm.